Gelmon has a patchwork history, as myself ansd others have stated.....after reviewing the data and filings, it looks like Gelmon is here to do one thing, raise Money in these Markets......for Clinical Trials ??.....Good DD on the Dr's who run OTS as well as the Board, actually quite impressive......regarding Clinical trials, nothing on the FDA site as of yet, Lots happening at Duke University, struggling with finding a Valentine.....looks to me like OTS may have some legitimacy, and commitment in Staff and Board to bring the Life Cradle and it's technology to market....as well as the 2nd subsidiary technology in the HPV Screening Area.........Gelmon does not maintain control of this one as he has others based on the data starting with:
Biographies of the Rest of this Group:
MICHAEL O. CHOO , 46, President & Chief Executive Officer of Bellflower Medical Center, Los Angeles, CA. Previously served as Principal, Managing Partner & President & Chief Executive Officer of Integra Healthcare, Inc., Principal, Managing Partner, & Chairman of The Board of Directors of Doctors ’ Hospital of Shreveport, and Principal, Managing Partner & Senior Vice President of Operations for Ethicus Healthcare Management, LLC. Mr. Choo was also previously the Senior Vice President of Promise Healthcare, Inc. and Chief Executive Officer of Promise Specialty Hospital of Shreveport, a 146 bed JCAHO long-term acute care, acute rehabilitation, gerontologic and adult psych turnaround hospital located in Shreveport, Louisiana. As second in command of the Company, he had corporate oversight of the Company ’ s 14 other facilities from the standpoint of corporate recruitment, new business development, and operational turnaround. Before his departure from Promise Healthcare, Inc., he brought together over 120+ collective years of corporate operational experience, leadership, structure, “ team concept ” and organization to the Promise Healthcare Executive team. Mr. Choo has over 29 years of experience in healthcare with expertise in Operational Executive Management, Hospital Turnarounds, Hospital Acquisitions, and Ground Floor Start-ups. He has vast experience in the clinical setting as well as the operational and organizational development & structure of hospitals and healthcare organizations to comply with state & federal regulatory agency guidelines. Mr. Choo is finishing his Masters degree in Business Administration from California Coast University, and served in executive positions with various hospitals and companies managing hospitals. He held a previous position as the Chief Executive Officer of HealthSouth in Reno a 63 Acute Rehabilitation Freestanding Hospital in Reno, NV acting as Team Leader for the HealthSouth Surgical center, and HealthSouth Sports Clinic in Carson City, NV. He also has been the Vice President of NPSI with responsibility for 4 major hospitals in the Los Angeles and San Diego area, and Regional Chief Operations Officer of ARMS with responsibilities for 5 hospital turnarounds and 2 ground floor start-ups. Mr. Choo brings experience from the acute care industry, LTAC industry, Behavioral Health Industry, and Acute Rehabilitation Industry to the organization.
CAROLINE PINELL , 39, is an attorney and medical doctor and currently serves as a high level healthcare operations consultant to various clients, including Hospitals, Independent Physician Associations, Physician Groups and Networks, Medical Practices, Attorneys, and various Medicare and Medicaid Health Plans. She was formerly President and Chief Executive Officer of ATRIO Health Plans, a Medicare Advantage (MA-PD) Plan located in Oregon. It services three counties including Douglas, Coos, and Klamath Counties with expansion plans in place for Washington County. The Plan covers approximately 4500 lives with significant growth expected over the next three years. The Provider Network included 99% of all providers in each of the counties it currently services. From 2006 to 2008, she served as Executive Vice President, Director of Physician Relations, Business Development and Managed Care for HCA-Bayshore Medical Center in Pasadena, Texas, and previously has served in management capacities with several large physician associations and provider networks.
Dr. Pinell studied medicine at the University of Texas Health Science Center and holds a JD degree from South Texas College of Law in Houston, Texas.
MICHAEL B. HOLDER is an experienced executive with over 2 5 years of demonstrated success in operational, fund raising, and transactional capacities . Mr . Holder is currently the Chairman and Chief Executive Office of Organ Transport Systems, Inc. Mr. Holder is also a Founder, Director and has served as acting CFO of Servergy Inc., a computer hardware company. Mr. Holder previously was a Vice President with and managed the technology solutions business for Premier Inc., an $18 billion hospital group purchasing organization and supplier . During Mr . Holder ’ s career, he has served as an executive wit h both another leading healthcare company, BeaconEye Inc., where he completed an IPO and a strategic sale of the company, and with the Sam Walton family private equity fund, Heartland Capital Partners. Mr . Holder has led corporate development activities for A M R Corpora t io n . Mr . Holder received his M.B.A . from the Wharton School of Business, his B.S . in Business Administration from the University of North Carolina, and previously earned a CPA designation in Texas .
HYMAN P. WHITE is the founder of Organ Transport Systems, Inc . and served as CEO until 2004 at which time he assumed his current positio n as Executive Vice President-Business Development, Secretary and Treasurer. . Prior to OTS, his career includes almost 30 years of experience in the medical technology and device marketplace primarily with Baxter, C.R Bar d , Motorola and TechLease . Mr . White served in and was honorably discharged from the United States Air Forc e . Mr . White earned his B.B.A . in Business and Marketing from the University of
North Texas.
Also LIKE the COMMITTEES, Gelmon is NOT on ANY OF THEM.....
The Company has established committees of the Board of Directors, and adopted appropriate committee charters. The current Committees of the Board, and their members, are:
Audit Committee:
Michael Choo, Chair
Caroline Pinell
Compensation Committee:
Michael Choo, Chair
Caroline Pinell
Governing and Nominating Committee:
Caroline Pinell (Chair)
Michael Choo
Hyman White
.....AND they have Gelmon on a Leash:
CODE OF ETHICS
We have adopted a code of ethics meeting the requirements of Section 406 of the Sarbanes-Oxley Act of 2002. We believe our code of ethics is reasonably designed to deter wrong doing and promote honest and ethical conduct; provide full, fair, accurate, timely and understandable disclosure in public reports; comply with applicable laws; ensure prompt internal reporting of violations; and provide accountability for adherence to the provisions of the code of ethic.
ITEM 11.
EXECUTIVE COMPENSATION
1 Mr. Gelmon receives a base salary of $10,000 per month as Chairman and CEO, commencing July 1, 2011. He was also awarded a grant of 500,000 shares of common stock, vesting annually over 5 years at 100,000 shares per year as of July 1 of each year. The July 1, 2011 grant of 100,000 shares was valued at $42,000, based on the closing price of $0.42 for the common stock on July 1, 2011
_____________
Amazing Run Up, and Congrats to those who made some dough, there may be a fighting Chance this has some legitimacy as a Company.....Time Tells All !
